Primary Prevention of Neutropenia by Empegfilgrastim in Patients with Advanced Stages of Classical Hodgkin Lymphoma Treated with Intensive First-Line Chemotherapy with a Modified 6-Cycle Program EACODD-14 Under the Protocol “LKh-Rossiya-1”

Aim. To assess the efficacy of a long-acting form of the granulocyte colony-stimulating factor (G-CSF) empegfilgrastim in primary prevention of neutropenia in patients with advanced stages of classical Hodgkin lymphoma (cHL) who received intensive chemotherapy with reduced inter-cycle interval under...

Descrición completa

Detalles Bibliográficos

Principais autores:	Anna Anatolevna Spornik, N. S. Vasilev, A. A. Samoilova, A. A. Mamedova, V. S. Bogatyrev, E. G. Smirnova, A. A. Bannikova, A. A. Rukavitsyn, N. S. Shorokhov, N. E. Mochkin, V. O. Sarzhevskii, E. A. Demina, V. Ya. Melnichenko
Formato:	Artigo
Idioma:	Russo
Publicado:	Practical Medicine Publishing House 2023-09-01
Series:	Клиническая онкогематология
Assuntos:	classical hodgkin lymphoma eacodd-14 eacoрр-14 empegfilgrastim treatment outcomes
Acceso en liña:	https://bloodjournal.ru/index.php/coh/article/view/48
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!